RecruitMe Clinical Trial

MULTI-INSTITUTIONAL STUDY TO EVALUATE DNA METHYLATION MARKERS FOR DETECTION OF PRIMARY BLADDER CANCERS IN URINE SAMPLES FROM A COHORT OF PATIENTS WITH HEMATURIA
MdxHealth: Study of Urine Samples in Patients with Hematuria (Blood in Urine)
Sponsor:MDxHealth
Enrolling:Male and Female Patients
Minimum Age:18 years old
IRB Number:AAAR1050
Contact: Research Nurse Navigator: 212-342-5162 / cancerclinicaltrials@cumc.columbia.edu
Additional Study Information:

This study is being conducted to evaluate the performance of the AssureMDx test for the detection of bladder cancer in patients presenting with hematuria.

This study is closed
Investigator
Joel DeCastro, MD
You may be eligible for this study

Place Holder




Who Can I Contact?
For more information, please contact:
Research Nurse Navigator
Email: cancerclinicaltrials@cumc.columbia.edu
Phone: 212-342-5162